Rashin lafiya na rashin lafiya tare da sakamako mai mahimmanci
Sauran mutane sukan rikita ƙwayar cutar kwayar cutar (MS) da cutar Alzheimer (AD) , nau'i biyu da ke nuna halin lalacewar wasu ayyuka na aikin neuro. Kowane yana tsayin daka cigaba da ci gaba da bayyanar cututtuka, kuma duka biyu suna da yiwuwar haifar da nakasa mai tsanani ga waɗanda aka cutar.
Amma, bayan waɗannan cututtuka, duka MS da AD suna da ƙari, siffofi, da kuma jiyya waɗanda suke gaba ɗaya.
Saboda haka, ana iya la'akari da su kamar 'yan uwan da ke kusa, tare da sananne kuma wasu lokuta suna kama da kamanni, maimakon dangantakar kai tsaye.
Difference a cikin dalilai
Yawancin ciwon sukarin yana dauke da mutane da yawa don zama rashin lafiyar mutum wanda ba shi da nasaba da shi na kansa yana haifar da lalacewa ga murya akan jijiyoyi (wanda ake kira sheathin sheath ). A matsayin haka, an classified MS a matsayin cutar da ke haifar da cututtukan da alamun cututtuka suke da alaka da lalacewar da wasu ɓangarorin na tsakiya ke ciki, ciki har da kwakwalwa, lakabi, da kuma jijiyoyin ƙwayoyi.
Duk da yake akwai sauran muhawara game da ainihin sassan MS, wasu masana kimiyya sun yarda cewa cutar tana iya haɗawa da cutar Epstein-Barr , kwayoyin halitta ko abubuwan da ke cikin muhalli, ko ma matsaloli tare da metabolization na bitamin D.
Dalilin abin da Alzheimer ya kasance ya kasance mai duhu. Kamar yadda yake tare da MS, abubuwan da suka shafi kwayoyin halitta, salon rayuwa, da kuma yanayi sunyi imani suyi wani ɓangare, duk da cewa duk abin da kowannensu ya bayar yana da mahimmanci.
Yayin da AD ba a la'akari da cututtuka ba ne, ana ganin lokacin da aka bayyana a lokacin da bayyanar bayyanar cututtuka (mafi yawancin lokuta ana danganta da rashin ƙwaƙwalwar ƙwaƙwalwa). Amma ba kamar MS ba, rashin cigaba da cutar ba shi da alaka da demyelination. Abin da muke gani a maimakon haka shine lalacewar ci gaba da mutuwa ga kwayoyin jijiya ( ƙananan hannu ) a kwakwalwa kanta.
Differences a cikin cututtukan cututtuka
Ba wai kawai hanyar da MS ke haifar da lalacewa ta jiki ba ya bambanta daga AD, saboda haka, ma, yi alamar bayyanar. Duk da yake akwai wasu farfadowa tsakanin cututtuka, MS yana haɗuwa da fadi da kewayo, motar, da kuma bayyanar cututtuka, yayin da Alzheimer ya fara nunawa tare da lalacewa.
Tare da MS, ciwo, damuwa, da ciwon tsoka zai iya zama tare da matsalar urinary, na gani, da kuma matsalolin yanayi.Da AD, a gefe guda, cutar ta nuna tare da rashi na halayen cognition (tunani, tunanin, ƙungiyoyi) sun haɗu tare da tsararren yanayi da kuma halayyar halayya.
Wadannan bambance-bambance suna da alaƙa da hanyoyin kowane irin cuta, ciki har da wadanda kwayoyin ke shafa, yadda aka kai su farmaki, da kuma lokacin.
- Tare da MS, bayyanar cututtuka suna dogara ne a kan inda aka yi la'akari da shi. Shirin ba kawai yana haifar da jijiyoyi don ɓarna ba, zai iya yin katsewa tsakanin sadarwa tsakanin sassan jiki. Yana da matsala wanda zai iya faruwa a kowane zamani daga 20 zuwa gaba.
- Tare da AD, alamun cututtuka suna da alaƙa da gina wasu sunadarai, wanda ake kira plaque, tsakanin kwayoyin jikinsu a kwakwalwa. Duk da yake ana daukar wannan tsari na al'ada ne a matsayin mutum mai shekaru, an ƙara da kuma karawa a cikin mutanen da ke tare da Alzheimer's. Saboda haka, yana nuna cewa za'a iya bincikar mutane fiye da 50 zuwa 60.
Differences a cikin Jiyya da sakamakon
Bisa ga bambance-bambance a cikin bayyanar cututtuka, ba zai zama ba mamaki cewa magani na MS da AD sun bambanta, da.
Jiyya na MS shine mafi yawan abubuwa biyu: raguwa da kumburi a cikin kwakwalwa da kyallen takalma tare da kwayoyin steroids da kwayoyi masu guba da ƙwayoyin cuta, da kuma saurin maganin rigakafi da kwayoyi masu kare lafiyar. Wasu magunguna da jiyya za a iya amfani dasu don sarrafawa ko gyara kuskure, rashin cin zarafin jima'i , matsalolin hangen nesa , ko rikici .
Duk da yake babu maganin warkar da MS, tare da kulawa da kulawa da kyau da ingancin rayuwa zai iya inganta sosai, tare da kashi 40 cikin dari suna rayuwa da kyau a cikin 70s.
Jiyya na AD ba shi da mahimmanci a cikin sakamako. Duk da yake akwai wasu ƙwayoyi masu tasowa na yau da kullum da ake samu a yau, amsawa zai iya bambanta. Babu magani da aka sani don warkewarta, baya, ko ma mahimmanci jinkirin cigaba da cutar. Bayan ganewar asali, kasa da kashi uku cikin dari na mutanen da aka gano tare da AD sun rayu fiye da shekaru 14.
> Sources:
> Burns, A. "Ciwon Bincike: Ciwon Alzheimer." BMJ. 2009; 338: b158.
> Tsang, B. da Macdonnell, R. "Magungunan sclerosis mai yawa - ganewar asali, gudanarwa, da ƙwarewa". Aus Fam Phys . 2011: 40 (12): 948-55.